Abstract:Patients with chronic obstructive pulmonary disease (COPD) are characterized by a variety of comorbid conditions, including both somatic (arterial hypertension, atherosclerosis, coronary heart disease, bronchial asthma, malignant neoplasms, diabetes mellitus, obesity, etc.) and mental (depressive disorders, suicide attempts). Against the background of various chronic diseases of the respiratory system, endocrine, metabolic disorders, the risks of exacerbations of COPD increase. The leading unifying mechanism of these conditions is systemic subclinical inflammation. Its excessive activity leads to the loss of the physiological functions of inflammation, which is accompanied by an imbalance in the endocrine system and the release of high concentrations of hormones and neurotransmitters. The result of this response is the uncoupling of cytokine mechanisms, which leads to an imbalance in the system of pro- and anti-inflammatory cytokines. The article describes the role of the pro-inflammatory chemokine IL-8 (interleukin 8), which is responsible for the migration of neutrophils to the site of inflammation. This is how the neutrophilic type of inflammation is formed. IL-4 and IL-10 are considered, which occupy a leading position in the formation of CD4+ type of immunoreactivity, which is observed in bronchial asthma. Attention is focused on the significance of IL-6, because it is an integral component of local and systemic inflammation. An increase in its concentration and, as a result, a potential risk of damage to the respiratory epithelium is the remodeling of the bronchial tree, resulting in a decrease in the elasticity of the epithelium of the respiratory tract. This mechanism leads to the formation of pulmonary emphysema and further potentiation of pathophysiological processes in patients with COPD. Since IL-6 is a cytokine with anti-inflammatory properties, its molecular activity is achieved by interacting with a special receptor complex consisting of two subunits: IL-6R and gp130. The former mediates IL-6 binding, while the latter triggers the JAK/STAT or MAPK signaling cascade pathways. The result of the reaction of IL-6 with the effector cell directly depends on the type of signaling. The paper describes three mechanisms of signal transduction into the target cell: classical, cluster, and transsignaling. Thus, by studying the role of cytokines in the systemic inflammatory response, we have shown the cross-talk between adipose tissue and the lungs in obesity, highlighting the main inflammatory mediators, which may indicate new therapeutic targets for preventing pulmonary dysfunction.

Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease

Lipid Metabolism In Chronic Obstructive Pulmonary Disease

Proresolving Lipid Mediators in the Respiratory System

Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease

Copd_a_196210 1009..1018

[Association of fatty acid metabolism with systemic inflammatory response in chronic respiratory diseases]

Lipid mediators of inhalation exposure-induced pulmonary toxicity and inflammation

Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation

Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

Old and new generation lipid mediators in acute inflammation and resolution

Lipid Mediators in Inflammatory Disorders

Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases

Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

The role of cytokines in the development of systemic inflammation in chronic obstructive pulmonary disease and obesity

Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer

N-3 PUFAs and their specialized pro-resolving lipid mediators on airway inflammatory response: beneficial effects in the prevention and treatment of respiratory diseases.